Alzheimer’s disease (AD) is still a major public health challenge without an effective treatment to prevent or stop it. Routinely used acetylcholinesterase inhibitors and memantine seem to slow disease progression on...Alzheimer’s disease (AD) is still a major public health challenge without an effective treatment to prevent or stop it. Routinely used acetylcholinesterase inhibitors and memantine seem to slow disease progression only to a limited extend. Therefore, many investigations on new drugs and other treatment modalities are ongoing in close association with increasing knowledge of the pathophysiology of the disease. Here, we review the studies about the new treatment modalities in AD with a classification based on their main targets, specifically pathologic structures of the disease, amyloid and tau, neural network dysfunction with special interest to the regulation of gamma oscillations, and attempts for the restoration of neural tissue via regenerative medicine. Additionally, we describe the evolving modalities related to gut microbiota, modulation, microglial function, and glucose metabolism.展开更多
阿尔茨海默病(Alzheimer's Disease,AD)是一种常见的神经退行性疾病,β-淀粉样蛋白(β-amyloid,Aβ)诱导的氧化应激是其重要的发病因素。Aβ通过与细胞表面的晚期糖基化终产物受体(Receptor for Advanced Glycationendproducts,RAGE...阿尔茨海默病(Alzheimer's Disease,AD)是一种常见的神经退行性疾病,β-淀粉样蛋白(β-amyloid,Aβ)诱导的氧化应激是其重要的发病因素。Aβ通过与细胞表面的晚期糖基化终产物受体(Receptor for Advanced Glycationendproducts,RAGE)结合诱发氧化应激损伤;也可以通过Aβ的第35位氨基酸残基蛋氨酸(Met-35)诱导氧化应激损伤;还可以插入脂质双分子层,催化自由基的产生,导致氧化应激损伤,参与AD发病。地黄饮子、左归丸、黄连解毒汤等经典方,补肾益智汤、黄精地龙方、还脑益聪方等当代验方可抑制自由基的生成,保护神经元免受氧化应激的伤害,从而防治AD。展开更多
文摘Alzheimer’s disease (AD) is still a major public health challenge without an effective treatment to prevent or stop it. Routinely used acetylcholinesterase inhibitors and memantine seem to slow disease progression only to a limited extend. Therefore, many investigations on new drugs and other treatment modalities are ongoing in close association with increasing knowledge of the pathophysiology of the disease. Here, we review the studies about the new treatment modalities in AD with a classification based on their main targets, specifically pathologic structures of the disease, amyloid and tau, neural network dysfunction with special interest to the regulation of gamma oscillations, and attempts for the restoration of neural tissue via regenerative medicine. Additionally, we describe the evolving modalities related to gut microbiota, modulation, microglial function, and glucose metabolism.
文摘阿尔茨海默病(Alzheimer's Disease,AD)是一种常见的神经退行性疾病,β-淀粉样蛋白(β-amyloid,Aβ)诱导的氧化应激是其重要的发病因素。Aβ通过与细胞表面的晚期糖基化终产物受体(Receptor for Advanced Glycationendproducts,RAGE)结合诱发氧化应激损伤;也可以通过Aβ的第35位氨基酸残基蛋氨酸(Met-35)诱导氧化应激损伤;还可以插入脂质双分子层,催化自由基的产生,导致氧化应激损伤,参与AD发病。地黄饮子、左归丸、黄连解毒汤等经典方,补肾益智汤、黄精地龙方、还脑益聪方等当代验方可抑制自由基的生成,保护神经元免受氧化应激的伤害,从而防治AD。